Septic shock; current pathogenetic concepts from a clinical perspective

Medical Science Monitor

Volumn 11, Issue 3, 2005, Pages

  Tsiotou, Adelais G ^a   Sakorafas, George H ^b,d   Anagnostopoulus, George ^b   Bramis, John ^c  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b 251 GENERAL AIR FORCE HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

Coagulation disorders; Complement activation; Cytokines; Endotexemia; Inflammatory mediators; Multiple organ dysfunction syndrome (MODS); Multiple organ failure (MOF); Myocardial depression; Sepsis; Septic shock

Indexed keywords

CYTOKINE;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; COMPLEMENT ACTIVATION; CRITICAL ILLNESS; CYTOKINE RELEASE; ENDOTOXEMIA; FIBRINOLYSIS; FUNGUS; GASTROINTESTINAL TRACT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; INFLAMMATION; MULTIPLE ORGAN FAILURE; REVIEW; SEPTIC SHOCK; SURGICAL PATIENT; VIRUS;

BLOOD COAGULATION DISORDERS; COMPLEMENT ACTIVATION; ENDOTHELIUM, VASCULAR; ENDOTOXEMIA; HUMANS; MODELS, BIOLOGICAL; MULTIPLE ORGAN FAILURE; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 15944362222     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Sands K, Bates D, Lanken P et al: Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA, 1997; 278: 234-40
2. Wheller AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med, 1999; 340: 207-14
3. Hardaway RM: A review of septic shock. Am Surg, 2000; 66: 22-29
4. van der Poll T, van Deventer JH: Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am, 1999; 13: 413-26
5. Galley HF, Webster NR: The immuno-inflammatory cascade. Br J Anaesth, 1996; 77: 11-16
6. Hack CE, Zeerleder S: The endothelium in sepsis: Source of and a target for inflammation. Crit Care Med, 2001; 29(Suppl): S21-S27
7. Evans TJ: The role of macrophages in septic shock. Immunology, 1996; 195(4-5): 655-59
8. Baker CC, Huynh T: Sepsis in the critically ill patient. Curr Probl Surg, 1995; 32: 1013-92
9. Aldridge AJ: Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg, 2002; 168: 204-14
10. Goya T, Morisaki T, Torisu M: Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery, 1994; 115: 145-55
11. Vane JR, Anggard EE, Bolting RM: Regulatory functions of the vascular endothelium. N Engl J Med, 1990; 323: 27-36
12. Balk RA: Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin, 2000; 16: 337-52
13. Casey LC: Immunologic response to infection and its role in septic shock. Crit Care Clin, 2000; 16: 193-213
14. Caladra T, Bochud PY. Heumann D: Cytokines in septic shock. Curr Clin Top Infect Dis, 2002; 22: 1-23
15. Herbertson MJ, Werner HA, Goddard CM et al: Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs. Am J Respir Crit Care Med, 1995; 152: 480-88
16. Johnson JL, Moore EE, Tamura DY et al: IL-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res, 1998; 76: 91-94
17. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines. Adv Immunol, 1994; 55: 97-179
18. Baggiolini M: Activation and recruitment of neutrophil leukocytes. Clin Exp Immunol, 1995; 101(Suppl. 1): 5-6
19. Gomez-Jimenez J, Martin MC, Sauri R et al: Interletikin 10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis. 1995; 171: 472-75
20. Fink MP: Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ronger's ethyl pyruvate solution. Curr Opin Clin Nutr Metab Care, 2002; 5: 167-74
21. Sakorafas GH, Tsiotos GG, Sarr MG: Ischemia/reperfusion induced pancreatitis. Dig Surg, 2000; 17: 3-14
22. Vincent JL, Zhang H, Szabo C et al: Effects of nitric oxide in septic shock. AmJ Respir Crit Care Med, 2000; 161: 1781-85
23. Sheehan M, Wong HR: Yet another potential role for nitric oxide in the pathophysiology of septic shock. Crit Care Med, 2002; 30: 1393-94
24. Murray PT, Wylam ME, Umans JG: Nitric oxide and septic vascular dysfunction. Anesth Analg, 2000; 90: 89-101
25. Bulger EM, Maier RV: Lipid mediators in the pathophysiology of critical illness. Crit Care Med, 2000; 28(Suppl.4): N 27-36
26. Freeman BA, Lynn WS: Fatty acid secretion and metabolism in "activated" rabbit alveolar macrophages. Biochim Biophys Acta, 1980; 620: 528-37
27. Morrow J, Awad J, Kato T et al: Formation of novel non-cyclooxygenase- derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest, 1992; 90: 2502-7
28. Tetta C, Mariano F, Buades J et al: Relevance of platelet-activating factor in inflammation and sepsis: Mechanisms and kinetics of removal in extracorporeal treatments. Am J Kidney Dis, 1997; 30: S57-S65
29. Fink MP: Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. J Antimicrob Chemother, 1998; 41(Suppl.A): 81-94
30. Versteeg HH, van Bergen en Henegouwen PM, van Deventer SJ et al: Cyclooxygenase-dependent signalling: Molecular events and consequences. FEBS Lett, 1999; 445: 1-5
31. Dosquet C, Weill D, Wautier JL: Cytokines and thrombosis. J Cardiovasc Pharmacol, 1995; 25(Suppl.2): S13-S19
32. Levi M: Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient J Crit Care, 2001; 16: 167-77
33. Gate H: Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med, 2000; 28(Suppl): S9-S11
34. Taylor F, Levi M, Artigas A et al: Sepsis: Inflammation disorder, coagulation disorder, or both? A challenge for clinicians. Crit Care Med, 2001; 29(Suppl): S107-S109
35. Haeney MR: The role of the complement cascade in sepsis. J Antimicrob Chemother, 1998; 41(SupplA): 41-46
36. Kirschfink M: Controlling the complement system in inflammation. Immunopharmacology, 1997; 38: 51-62
37. Hassoun HT, Kone BC, Mercer DW et al: Post-injury multiple organ failure: the role of the gut. Shock, 2001; 15: 1-10
38. Swank GM, Deitch EA: Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg, 1996; 20: 411-17
39. Grouser ED, Dorinsky PM: Gastrointestinal tract dysfunction in critical illness: Pathophysiology and interaction with acute lung injury in adult respiratory distress syndrome / multiple organ dysfunction syndrome. New Orizons, 1994; 2: 476-87
40. Strassburg CP: Shock liver. Best Pract Res din Gastroenterol, 2003; 17: 369-81
41. Dhainaut J-F, Marin N, Mignon A, Vinsonneau C: Hepatic response to sepsis: Interaction between coagulation and inflammatory process. Crit Care Med, 2001; 29(Suppl): S42-S47
42. Doi F, Goya T, Torisu M: Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis. Hepatology, 1993; 17: 1086-94
43. Court O, Kiimar A, Parrulo JE, Kumar A: Myocardial depression in sepsis and septic shock. Crit Care, 2002; 6: 500-8
44. Balk RA: Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin, 2000; 16: 337-52
45. Parker MM, McCarthy KE, Ognibene FP, Parillo JE: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest, 1990; 97: 126-31
46. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock. Crit Care Clin, 2000; 16: 251-88
47. Haslett C, Savill J: Why is apoptosis important to clinicians? BMJ, 2001; 322: 1499-500
48. Hotchkiss RS, Swanson PE, Freeman BD: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med, 1999; 27: 1230-51
49. Hotchkiss RS, Tinsley KVV, Swanson PE: Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol, 2001; 166: 6952-63
50. Oberholzer K, Oberhoizer A, Clare-Salzeer M, Moldawer LL: Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J, 2001; 15: 879-92
51. Fukuzuka K, Edwards CK III, Clare-Salzler M et al: Glycocorticoid- induced, caspase-dependent organ apoptosis early after burn injury. Am J Physiol Regul Integr Comp Physiol, 2000; 278: R1005-R1018
52. Voll RE, Herrmann M, Roth EA et al: Immunosuppressive effects of apoptotic cells. Nature, 1997; 390: 350-51
53. Tracey KJ: The inflammatory reflex. Nature, 2002; 420(6917): 853-59
54. Berczi I: Neuroendocrine response to endotoxin. Ann N Y Acad Sci, 1998; 851: 411-15
55. van Mook WN, Hulsewe-Evers RP: Critical illness polyneuropathy. Curr Opin Crit Care, 2002; 8: 302-10
56. Bolton CF: Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations. Crit Care Med, 1996; 24: 1408-16
57. McIntyre L, Walley KR: Importance of underlying mechanism and genotype on outcome of sepsis trials. Crit Care Med, 2001; 29: 677-79
58. Kumar A, Short J, Parillo JE: Genetic factors in septic shock. JAMA, 1999; 282: 579-81
59. 2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study, JAMA, 1999; 282: 561-68
60. van der Pol WL, Huizinga TW, Vidarsson G: Relevance of Fc gamma receptor and IL-10 polymorphisms for meningococcal disease. J Infect Dis, 2001; 184: 1548-55
61. van Deventer SJ: Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med, 2000; 26(Suppl.1): S98-S102
62. Wheller AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med, 1999; 340: 207-14
63. Michie HR: Metabolism of sepsis and multiple organ failure. World J Surg, 1996; 20: 460-64
64. Barton R, Cerra FB: The hypermetabolism: Multiple organ failure syndrome. Chest, 1989; 96: 1153-60
65. Douzinas EE, Tsismetziadou PD, Pitardis MT et al: The regional production of cytokines and lactate in sepsis-related multiple organ failure. Am J Respir Crit Care Med, 1997; 155: 53-59
66. Mizock BA: Metabolic derangements in sepsis and septic shock. Crit Care Clin, 2000; 16: 319-36
67. Fink M: Cytopathic hypoxia in sepsis. Acta Anaesth Scand, 1997; 110(Suppl): 87-115
68. Bochud FY, Glauser MP, Caladra T: Antibiotics in sepsis. Intensive Care Med, 2001; 27(Suppl.1): S33-S48
69. Alexander C, Rietschel ET: Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res, 2001; 7: 167-202
70. Bemal A, Proft T, Fraser JD: Superantigens in human disease. J Clin Immunol, 1999; 19: 149-57
71. Richards MJ, Edwards JR, Culver DH et al: Nosocomial infections in medical intensive care units in the United States. Crit Care Med, 1999; 27: 887-92
72. Simon D, Trenholme G: Antibiotic selection for patients with septic shock. Crit Care din, 2000; 16: 215-31
73. Brun-Buisson C, Doyon F, Carlet J et al: Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med, 1996; 154: 617-23
74. Linden P, Pasculle A, Manez R et al: Differences in outcomes for patients with bacteremia due to Vancomycin-resistant Enterococcus faecium or Vancomycin - susceptible E. faecium. Clin Infect Dis, 1996; 22: 663-68
75. Miller P, Wenzel R: Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis, 1987; 156: 471-78
76. Wenzel R: Nosocomial candidemia: Risk factors and attributable mortality, Clin Infect Dis, 1995; 20: 1531-38
77. Kieft H, Hoepelman AI, Zhou W et al: The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med, 1993; 153: 2241-47
78. Sakorafas GH: Multiple organ failure as an indication for exploratory laparotomy. Iatriki, 1989, 56: 37-42 (GR)
79. Sakorafas GH: Multiple organ failure syndrome, Monograph, Diaton Ed, Athens 1990, pp 50
80. Ranger-Frausto MS, Pittet D, Costigan M et al: The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA, 1995; 273: 117-23
81. Darby JM, Linden P, Pasculle W, Saul M: Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. Crit Care Med, 1997; 25: 989-94
82. Cristofaro P, Opal SM: The Toll-like receptors and their role in septic shock. Expert Opin Ther Targets, 2003; 7: 603-12
83. Sakai Y, Masamune A, Satoh A et al: Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology, 2003; 124: 725-36
84. Anderson UG, Tracey KJ: HMGB1, a pro-inflammatory cytokine of clinical interest: introduction. J Intern Med, 2004; 255: 318-19
85. Andersson U, Tracey KJ: HMGB1 in sepsis. Scand J Infect Dis, 2003; 35: 577-84
86. Colonna M, Facchetti F: TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis, 2003; 187(Suppl.2): S397-401
87. Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature, 2001; 410(6832): 1103-7
88. Tsiotou AG, Sakorafas GH: Management of septic shock; current concepts with a particular emphasis on the role of source control and future perspectives. Eur J Anaesthesiol, 2004; 21(5): 337-60
89. Das UN. Current advances in sepsis and septic shock with particular emphasis on the role of insulin. Med Sci Monit, 2003; 9(8): RA181-RA192
90. Dellinger RP, Carlet JM, Masur H et al: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004; 32: 858-73